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Background
Allergy to cat is a frequent cause of rhinitis, asthma or
contact urticaria. Dander, saliva and urine are sources of
cat allergens. The prevalence of sensitization to different
cat allergens is not well known.
Methods
We select 105 sensitized patients to cat. Specific IgE mea-
surement to cat allergens Fel d1, Fel d2 and Fel d4 was
performed by ImmunoCAP® and/or microarray ISAC®
(ThermoFisher Scientific, Sweden), a value > 0,35 kU/L or
>0,3 ISU was considered as positive, respectively. Skin
prick test was performed with an ALK-Abelló extract
(Denmark). Association of Specific IgE measurements and
presence and type of rhinitis or asthma was studied.
Statistical analysis was performed using Fisher test and
chi-squared test.
Results
88% of patients had specific IgE to Fel d1, 22% to Fel d2,
and 42% to Fel d4. 48% were monosensitized to Fel d1,
7% to Fel d2 and 4% to Fel d4. 86% of sensitized patients
to Fel d4 were also sensitized to Fel d1. Fel d2 was asso-
ciated with severity of rhinitis and asthma (p <0.01,
p 0.01, respectively). Fel d4 was associated with presence
of asthma symptoms (p<0.04). Direct contact with cats
was associated both to persistence and severity of rhinitis
(p 0.0003, p 0.0001, respectively). A positive skin prick
test to cat was associated with rhinitis and asthma symp-
toms (p < 0.01, p <0.01, respectively).
Conclusion
Different patterns of sensitization to cat allergens in
patients with cat allergy can help us to predict the severity
and persistence of symptoms.
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